Insider ownership feed
Showing Forms 3/4/5 accepted since 26 May 2026. Each row keeps issuer, reporting owner, reported value, role, and SEC evidence together.
Recent insider signals
Use the card actions for issuer context, owner profile, and SEC evidence.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Form 4 insider conviction
Role, issuer, transaction value, repeat activity, and SEC evidence.
Fresh reports
21,193
Forms 3, 4, and 5 filed in the current review window.
Visible buy/sell mix
0/1
Positive/negative net value among the preview cards.
Visible net value
-$2,925,909
Directional preview only; verify transaction rows and footnotes.
Newest evidence
29 May 2026
Use recency to separate fresh activity from stale insider stories.
Signal checks
positive net value and transaction code
multiple insiders or repeated filings
director, officer, or 10% owner context
issuer facts, 13D/G stakes, and 13F holders
SEC-verifiable Form 4 path
Open the filing, then follow the insider, issuer, or related ownership context.
Leslie Norwalk V filed Form 4 for NEUROCRINE BIOSCIENCES INC (NBIX). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
Sean E. Quinn filed Form 4 for CIMPRESS plc (CMPR). Role/context: EVP, Chief Financial Officer. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
Douglas Joseph Hirsch filed Form 4 for GoodRx Holdings, Inc. (GDRX). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
Fairmount Funds Management LLC filed Form 4 for Spyre Therapeutics, Inc. (SYRE). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
Ronald E. Bruehlman filed Form 4 for GoodRx Holdings, Inc. (GDRX). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
James N. Wilson filed Form 4 for CORCEPT THERAPEUTICS INC (CORT). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
| Security | Issuer | Reporting owner / CIK | Reported value | Report date | Actions |
|---|---|---|---|---|---|
| NBIX | NEUROCRINE BIOSCIENCES INC | Leslie Norwalk V CIK 0001533568 | $0 | 27 May 2026 | |
| CMPR | CIMPRESS plc | Sean E. Quinn CIK 0001621706 | -$2,925,909 | 27 May 2026 | |
| GDRX | GoodRx Holdings, Inc. | Douglas Joseph Hirsch CIK 0001822522 | $0 | 27 May 2026 | |
| SYRE | Spyre Therapeutics, Inc. | Fairmount Funds Management LLC CIK 0001802528 | $0 | 27 May 2026 | |
| GDRX | GoodRx Holdings, Inc. | Ronald E. Bruehlman CIK 0001604076 | $0 | 27 May 2026 | |
| CORT | CORCEPT THERAPEUTICS INC | James N. Wilson CIK 0001236387 | $0 | 27 May 2026 | |
| SYRE | Spyre Therapeutics, Inc. | Jeffrey W. Albers CIK 0001638474 | $0 | 27 May 2026 | |
| SYRE | Spyre Therapeutics, Inc. | Michael Thomas Henderson CIK 0001779990 | $0 | 27 May 2026 | |
| SYRE | Spyre Therapeutics, Inc. | Laurie Stelzer CIK 0001644348 | $0 | 27 May 2026 | |
| SYRE | Spyre Therapeutics, Inc. | Mark C. McKenna CIK 0001749623 | $0 | 27 May 2026 | |
| SYRE | Spyre Therapeutics, Inc. | Sandra Milligan CIK 0001859810 | $0 | 27 May 2026 | |
| SPOT | Spotify Technology S.A. | Christopher P. Marshall CIK 0001440008 | $0 | 28 May 2026 | |
| PLD | Prologis, Inc. | Daniel Letter CIK 0001960640 | $0 | 29 May 2026 | |
| TNET | TRINET GROUP, INC. | Wayne B. Lowell CIK 0001263523 | $0 | 27 May 2026 | |
| OPBK | OP Bancorp | Ki Won Yoon CIK 0001734744 | $0 | 28 May 2026 | |
| OPBK | OP Bancorp | Myung Shin Sohn CIK 0002028878 | $0 | 28 May 2026 | |
| OPBK | OP Bancorp | Hyung J. Kim CIK 0001981564 | $0 | 28 May 2026 | |
| KTOS | KRATOS DEFENSE & SECURITY SOLUTIONS, INC. | Stacey G. Rock CIK 0001342017 | -$261,872 | 28 May 2026 | |
| EXEL | EXELIXIS, INC. | Stelios Papadopoulos CIK 0001202098 | $0 | 27 May 2026 | |
| OPBK | OP Bancorp | Sunny Kwon CIK 0001981563 | $0 | 28 May 2026 | |
| EXEL | EXELIXIS, INC. | Tomas J. Heyman CIK 0001814673 | $0 | 27 May 2026 | |
| EXEL | EXELIXIS, INC. | Sue Gail Eckhardt CIK 0001823769 | $0 | 27 May 2026 | |
| EXEL | EXELIXIS, INC. | Julie Smith CIK 0001557928 | $0 | 27 May 2026 | |
| EXEL | EXELIXIS, INC. | Maria C. Freire CIK 0001547999 | $0 | 27 May 2026 | |
| EXEL | EXELIXIS, INC. | Mary C. Beckerle CIK 0001520181 | $0 | 27 May 2026 | |
| EXEL | EXELIXIS, INC. | Bob Oliver CIK 0001694534 | $0 | 27 May 2026 | |
| EXEL | EXELIXIS, INC. | Jack L. Wyszomierski CIK 0001023225 | $0 | 27 May 2026 | |
| EXEL | EXELIXIS, INC. | George Poste CIK 0001180770 | $0 | 27 May 2026 | |
| OPBK | OP Bancorp | Yong Sin Shin CIK 0001734650 | $0 | 28 May 2026 | |
| OPBK | OP Bancorp | Min Kim CIK 0001734743 | $0 | 28 May 2026 | |
| GEVO | Gevo, Inc. | Gary W. Mize CIK 0001530501 | $0 | 27 May 2026 | |
| INAB | IN8BIO, INC. | Emily Fairbairn CIK 0001682638 | $0 | 27 May 2026 | |
| GEVO | Gevo, Inc. | Andrew Marsh CIK 0001431827 | $0 | 27 May 2026 | |
| GEVO | Gevo, Inc. | Jaime Guillen CIK 0001876001 | $0 | 27 May 2026 | |
| GEVO | Gevo, Inc. | Mary Kathryn Ellet CIK 0002006415 | $0 | 27 May 2026 | |
| PLXS | PLEXUS CORP | Todd P. Kelsey CIK 0001411282 | -$274,750 | 27 May 2026 | |
| GEVO | Gevo, Inc. | William H. Baum CIK 0001231857 | $0 | 27 May 2026 | |
| GEVO | Gevo, Inc. | James J. Barber CIK 0001377811 | $0 | 27 May 2026 | |
| GEVO | Gevo, Inc. | Patrick R. Gruber CIK 0001511369 | -$328,148 | 27 May 2026 | |
| MCRI | MONARCH CASINO & RESORT INC | John Farahi CIK 0000937318 | -$604,200 | 28 May 2026 | |
| PI | IMPINJ INC | Daniel Patrick Gibson CIK 0001745725 | $0 | 28 May 2026 | |
| GLP | GLOBAL PARTNERS LP | Global GP LLC CIK 0001339396 | +$722,550 | 27 May 2026 | |
| GEVO | Gevo, Inc. | Andrew Shafer CIK 0001999254 | -$57,487 | 27 May 2026 | |
| GEVO | Gevo, Inc. | Bowron Kimberly T. CIK 0001866673 | -$44,173 | 27 May 2026 | |
| GEVO | Gevo, Inc. | Oluwagbemileke Yusuf Agiri CIK 0002071241 | -$56,652 | 27 May 2026 | |
| PI | IMPINJ INC | Arthur L. Valdez Jr. CIK 0001821687 | $0 | 28 May 2026 | |
| GEVO | Gevo, Inc. | Christopher Michael Ryan CIK 0001512143 | -$154,334 | 27 May 2026 | |
| MATX | Matson, Inc. | Grace M. Cerocke CIK 0001844606 | -$220,284 | 28 May 2026 | |
| GEVO | Gevo, Inc. | Paul D. Bloom CIK 0001854032 | -$133,278 | 27 May 2026 | |
| OVLY | Oak Valley Bancorp | Allison C. Lafferty CIK 0001719092 | +$2,909 | 28 May 2026 |